Year |
Citation |
Score |
2016 |
Ebbert MT, Wadsworth ME, Staley LA, Hoyt KL, Pickett B, Miller J, Duce J, Kauwe JS, Ridge PG. Evaluating the necessity of PCR duplicate removal from next-generation sequencing data and a comparison of approaches. Bmc Bioinformatics. 17: 239. PMID 27454357 DOI: 10.1186/S12859-016-1097-3 |
0.65 |
|
2016 |
Bodily PM, Fujimoto MS, Page JT, Clement MJ, Ebbert MT, Ridge PG. A novel approach for multi-SNP GWAS and its application in Alzheimer's disease. Bmc Bioinformatics. 17: 268. PMID 27453991 DOI: 10.1186/S12859-016-1093-7 |
0.652 |
|
2016 |
Ebbert MT, Staley LA, Parker J, Parker S, Bailey M, Ridge PG, Goate AM, Kauwe JS. Variants in CCL16 are associated with blood plasma and cerebrospinal fluid CCL16 protein levels. Bmc Genomics. 17: 437. PMID 27357396 DOI: 10.1186/S12864-016-2788-X |
0.683 |
|
2016 |
Staley LA, Ebbert MT, Bunker D, Bailey M, Ridge PG, Goate AM, Kauwe JS. Variants in ACPP are associated with cerebrospinal fluid Prostatic Acid Phosphatase levels. Bmc Genomics. 17: 439. PMID 27357282 DOI: 10.1186/S12864-016-2787-Y |
0.663 |
|
2016 |
Hippen AA, Ebbert MT, Norton MC, Tschanz JT, Munger RG, Corcoran CD, Kauwe JS. Presenilin E318G variant and Alzheimer's disease risk: the Cache County study. Bmc Genomics. 17: 438. PMID 27357204 DOI: 10.1186/S12864-016-2786-Z |
0.615 |
|
2016 |
Staley LA, Ebbert MT, Parker S, Bailey M, Ridge PG, Goate AM, Kauwe JS. Genome-wide association study of prolactin levels in blood plasma and cerebrospinal fluid. Bmc Genomics. 17: 436. PMID 27357110 DOI: 10.1186/S12864-016-2785-0 |
0.672 |
|
2016 |
Pickett BD, Karlinsey SM, Penrod CE, Cormier MJ, Ebbert MT, Shiozawa DK, Whipple CJ, Ridge PG. SA-SSR: A Suffix Array-Based Algorithm for Exhaustive and Efficient SSR Discovery in Large Genetic Sequences. Bioinformatics (Oxford, England). PMID 27170037 DOI: 10.1093/Bioinformatics/Btw298 |
0.566 |
|
2016 |
Chen T, Moore TM, Ebbert MT, McVey NL, Madsen SR, Hallowell DM, Harris AM, Char RE, Mackay RP, Hancock CR, Hansen JM, Kauwe JS, Thomson DM. LIVER KINASE B1 INHIBITS THE EXPRESSION OF INFLAMMATION-RELATED GENES POST-CONTRACTION IN SKELETAL MUSCLE. Journal of Applied Physiology (Bethesda, Md. : 1985). jap.00727.2015. PMID 26796753 DOI: 10.1152/Japplphysiol.00727.2015 |
0.449 |
|
2015 |
Ebbert MT, Boehme KL, Wadsworth ME, Staley LA, Mukherjee S, Crane PK, Ridge PG, Kauwe JS. Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26449541 DOI: 10.1016/J.Jalz.2015.08.163 |
0.679 |
|
2015 |
Ebbert MT, Ridge PG, Kauwe JS. Bridging the Gap between Statistical and Biological Epistasis in Alzheimer's Disease. Biomed Research International. 2015: 870123. PMID 26075270 DOI: 10.1155/2015/870123 |
0.703 |
|
2015 |
Lythgoe C, Perkes A, Peterson M, Schmutz C, Leary M, Ebbert MT, Ridge PG, Norton MC, Tschanz JT, Munger RG, Corcoran CD, Kauwe JS. Population-based analysis of cholesteryl ester transfer protein identifies association between I405V and cognitive decline: the Cache County Study. Neurobiology of Aging. 36: 547.e1-3. PMID 25260850 DOI: 10.1016/J.Neurobiolaging.2014.08.022 |
0.676 |
|
2014 |
Ebbert MT, Wadsworth ME, Boehme KL, Hoyt KL, Sharp AR, O'Fallon BD, Kauwe JS, Ridge PG. Variant Tool Chest: an improved tool to analyze and manipulate variant call format (VCF) files. Bmc Bioinformatics. 15: S12. PMID 25080132 DOI: 10.1186/1471-2105-15-S7-S12 |
0.678 |
|
2014 |
Cruchaga C, Ebbert MT, Kauwe JS. Genetic discoveries in AD using CSF amyloid and tau. Current Genetic Medicine Reports. 2: 23-29. PMID 24729949 DOI: 10.1007/S40142-014-0031-0 |
0.557 |
|
2014 |
Ebbert MT, Ridge PG, Wilson AR, Sharp AR, Bailey M, Norton MC, Tschanz JT, Munger RG, Corcoran CD, Kauwe JS. Population-based analysis of Alzheimer's disease risk alleles implicates genetic interactions. Biological Psychiatry. 75: 732-7. PMID 23954108 DOI: 10.1016/J.Biopsych.2013.07.008 |
0.702 |
|
2013 |
Ridge PG, Ebbert MT, Kauwe JS. Genetics of Alzheimer's disease. Biomed Research International. 2013: 254954. PMID 23984328 DOI: 10.1155/2013/254954 |
0.706 |
|
2013 |
Gonzalez Murcia JD, Schmutz C, Munger C, Perkes A, Gustin A, Peterson M, Ebbert MT, Norton MC, Tschanz JT, Munger RG, Corcoran CD, Kauwe JS. Assessment of TREM2 rs75932628 association with Alzheimer's disease in a population-based sample: the Cache County Study. Neurobiology of Aging. 34: 2889.e11-3. PMID 23855982 DOI: 10.1016/J.Neurobiolaging.2013.06.004 |
0.587 |
|
2013 |
Gonzalez J, Schmutz C, Kauwe J, Munger C, Perkes A, Gustin A, Ebbert M, Norton M, Tschanz J, Munger R, Corcoran C. Assessment of TREM2 R47H in a population-based sample: The Cache County Study Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.1088 |
0.531 |
|
2013 |
Ebbert M, Ridge P, Wilson A, Sharp A, Bailey M, Norton M, Tschanz J, Munger R, Corcoran C, Kauwe J. P3-005: Population-based analysis of late-onset Alzheimer's disease risk alleles identifies candidate gene-gene interactions Alzheimer's & Dementia. 9: P551-P551. DOI: 10.1016/J.Jalz.2013.05.1074 |
0.713 |
|
Low-probability matches (unlikely to be authored by this person) |
2010 |
Nielsen TO, Parker JS, Leung S, Voduc D, Ebbert M, Vickery T, Davies SR, Snider J, Stijleman IJ, Reed J, Cheang MC, Mardis ER, Perou CM, Bernard PS, Ellis MJ. A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 5222-32. PMID 20837693 DOI: 10.1158/1078-0432.Ccr-10-1282 |
0.272 |
|
2012 |
Sweeney C, Bernard PS, Factor R, Shakespear K, Kwan ML, Habel LA, Stijleman IJ, Davis CA, Ebbert M, Kushi LH, Caan BJ. Abstract 1670: Molecular subtypes from PAM50 in a breast cancer cohort: differences by patient characteristic, reproducibility Cancer Research. 72: 1670-1670. DOI: 10.1158/1538-7445.Am2012-1670 |
0.252 |
|
2007 |
Carroll H, Beckstead W, O'Connor T, Ebbert M, Clement M, Snell Q, McClellan D. DNA reference alignment benchmarks based on tertiary structure of encoded proteins. Bioinformatics (Oxford, England). 23: 2648-9. PMID 17686799 DOI: 10.1093/Bioinformatics/Btm389 |
0.246 |
|
2013 |
Ma CX, Ellis MJ, Petroni GR, Guo Z, Cai SR, Ryan CE, Craig Lockhart A, Naughton MJ, Pluard TJ, Brenin CM, Picus J, Creekmore AN, Mwandoro T, Yarde ER, Reed J, ... Ebbert M, et al. A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer. Breast Cancer Research and Treatment. 137: 483-92. PMID 23242585 DOI: 10.1007/S10549-012-2378-9 |
0.237 |
|
2009 |
Carey L, O'Shaughnessy J, Hoadley K, Khambata-Ford S, Horak C, Xu L, Awad M, Brickman D, Muller S, Donato J, Asmar L, Stiljeman I, Ebbert M, Bernard P, Perou C. Potential Predictive Markers of Benefit from Cetuximab in Metastatic Breast Cancer: An Analysis of Two Randomized Phase 2 Trials. Cancer Research. 69: 2014-2014. DOI: 10.1158/0008-5472.Sabcs-09-2014 |
0.21 |
|
2007 |
Ebbert MT, Beckstead WA, O'Connor TD, Clement MJ, McClellan DA. Pharmacogenomics: analysing SNPs in the CYP2D6 gene using amino acid properties. International Journal of Bioinformatics Research and Applications. 3: 471-9. PMID 18048313 DOI: 10.1504/Ijbra.2007.015415 |
0.181 |
|
2011 |
Ebbert MT, Bastien RR, Boucher KM, Martín M, Carrasco E, Caballero R, Stijleman IJ, Bernard PS, Facelli JC. Characterization of uncertainty in the classification of multivariate assays: application to PAM50 centroid-based genomic predictors for breast cancer treatment plans. Journal of Clinical Bioinformatics. 1: 37. PMID 22196354 DOI: 10.1186/2043-9113-1-37 |
0.164 |
|
2022 |
Cadiz MP, Jensen TD, Sens JP, Zhu K, Song WM, Zhang B, Ebbert M, Chang R, Fryer JD. Culture shock: microglial heterogeneity, activation, and disrupted single-cell microglial networks in vitro. Molecular Neurodegeneration. 17: 26. PMID 35346293 DOI: 10.1186/s13024-022-00531-1 |
0.136 |
|
2012 |
Kelly CM, Bernard PS, Krishnamurthy S, Wang B, Ebbert MT, Bastien RR, Boucher KM, Young E, Iwamoto T, Pusztai L. Agreement in risk prediction between the 21-gene recurrence score assay (Oncotype DX®) and the PAM50 breast cancer intrinsic Classifier™ in early-stage estrogen receptor-positive breast cancer. The Oncologist. 17: 492-8. PMID 22418568 DOI: 10.1634/theoncologist.2012-0007 |
0.134 |
|
2014 |
Sweeney C, Bernard PS, Factor RE, Kwan ML, Habel LA, Quesenberry CP, Shakespear K, Weltzien EK, Stijleman IJ, Davis CA, Ebbert MT, Castillo A, Kushi LH, Caan BJ. Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 714-24. PMID 24521995 DOI: 10.1158/1055-9965.Epi-13-1023 |
0.125 |
|
2012 |
Bastien RR, RodrÃguez-Lescure Ã, Ebbert MT, Prat A, Munárriz B, Rowe L, Miller P, Ruiz-Borrego M, Anderson D, Lyons B, Ãlvarez I, Dowell T, Wall D, Seguà MÃ, Barley L, et al. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers. Bmc Medical Genomics. 5: 44. PMID 23035882 DOI: 10.1186/1755-8794-5-44 |
0.117 |
|
2012 |
Cheang MC, Voduc KD, Tu D, Jiang S, Leung S, Chia SK, Shepherd LE, Levine MN, Pritchard KI, Davies S, Stijleman IJ, Davis C, Ebbert MT, Parker JS, Ellis MJ, et al. Responsiveness of intrinsic subtypes to adjuvant anthracycline substitution in the NCIC.CTG MA.5 randomized trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 2402-12. PMID 22351696 DOI: 10.1158/1078-0432.Ccr-11-2956 |
0.109 |
|
2011 |
Bastien RR, Ebbert MT, Boucher KM, Kelly CM, Wang B, Iwamoto T, Krishnamurthy S, Pusztai L, Bernard PS. Using the PAM50 breast cancer intrinsic classifier to assess risk in ER+ breast cancers: A direct comparison to Oncotype DX. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 503. PMID 28021372 DOI: 10.1200/jco.2011.29.15_suppl.503 |
0.107 |
|
2013 |
MartÃn M, Prat A, RodrÃguez-Lescure A, Caballero R, Ebbert MT, Munárriz B, Ruiz-Borrego M, Bastien RR, Crespo C, Davis C, RodrÃguez CA, López-Vega JM, Furió V, GarcÃa AM, Casas M, et al. PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer. Breast Cancer Research and Treatment. 138: 457-66. PMID 23423445 DOI: 10.1007/S10549-013-2416-2 |
0.093 |
|
2013 |
Ebbert MT, Mallory MA, Wilson AR, Dooley SK, Hillyard DR. Application of a new informatics tool for contamination screening in the HIV sequencing laboratory. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 57: 249-53. PMID 23583427 DOI: 10.1016/j.jcv.2013.03.013 |
0.093 |
|
2011 |
Bernard PS, Davis C, Munarriz B, Stijleman IJ, Ruiz-Borrego M, Ebbert MT, Rodriguez-Lescure A, Bastien RR, Crespo C, Perou CM, Rodriguez C, Aranda FI, Furió V, Alvarez I, Seguí MA, et al. Determining agreement between immunohistochemistry and RT-qPCR for standard biomarkers in breast cancer: Validation on GEICAM 9906 clinical trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 611. PMID 28020639 DOI: 10.1200/Jco.2011.29.15_Suppl.611 |
0.087 |
|
2011 |
Ebbert MT, Bastien RR, Rowe LR, Miller PA, Anderson D, Boucher KM, Pappas LM, Fauron C, Lyons BW, Dowell T, Wall DE, Barley L, Bernard PS. PAM50 breast cancer intrinsic classifier: Clinical validation of a multianalyte laboratory developed test. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 10597. PMID 28022017 DOI: 10.1200/jco.2011.29.15_suppl.10597 |
0.085 |
|
2017 |
Mallory MA, Lucic D, Ebbert MT, Cloherty GA, Toolsie D, Hillyard DR. Evaluation of the Abbott RealTime HCV genotype II plus RUO (PLUS) assay with reference to core and NS5B sequencing. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 90: 26-31. PMID 28324789 DOI: 10.1016/j.jcv.2017.03.007 |
0.076 |
|
2012 |
Liu J, Welm B, Boucher KM, Ebbert MT, Bernard PS. TRIM29 functions as a tumor suppressor in nontumorigenic breast cells and invasive ER+ breast cancer. The American Journal of Pathology. 180: 839-47. PMID 22138580 DOI: 10.1016/j.ajpath.2011.10.020 |
0.069 |
|
2009 |
Beckstead WA, Ebbert MT, Rowe MJ, McClellan DA. Evolutionary pressure on mitochondrial cytochrome b is consistent with a role of CytbI7T affecting longevity during caloric restriction. Plos One. 4: e5836. PMID 19503808 DOI: 10.1371/Journal.Pone.0005836 |
0.064 |
|
2011 |
DeRose YS, Wang G, Lin YC, Bernard PS, Buys SS, Ebbert MT, Factor R, Matsen C, Milash BA, Nelson E, Neumayer L, Randall RL, Stijleman IJ, Welm BE, Welm AL. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nature Medicine. 17: 1514-20. PMID 22019887 DOI: 10.1038/nm.2454 |
0.058 |
|
Hide low-probability matches. |